 |
Subscribe / Renew |
 |
Contact Us |
| ► Subscribe to our Free Weekly Newsletter | |
Construction Bids
| home | Welcome, sign in or click here to subscribe. | login |
Business
 print  email to a friend  reprints add to mydjc |  |
March 11, 2020
NanoSurface Biomedical
Seattle biotechnology company NanoSurface Biomedical received $1.9 million in funding from the National Institutes of Health for development of stem cell-based platforms that help pharmaceutical companies accelerate drug development. NanoSurface previously received $1.2 million from NIH.